We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Beware mis‐representation of PRODIGE 7: danger of throwing out the cytoreductive surgery baby with the hyperthermic intraperitoneal chemotherapy bathwater.
- Authors
Koh, Cherry E.; Ansari, Nabila; Morris, David; Moran, Brendan
- Abstract
Beware mis-representation of PRODIGE 7: danger of throwing out the cytoreductive surgery baby with the hyperthermic intraperitoneal chemotherapy bathwater Over the past two decades, the combination of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has been increasingly considered optimal treatment for selected patients with resectable colorectal peritoneal metastases (CPM). In a subset analysis, patients with mid-range PCI of 11-15 appeared to have prolonged overall and disease-free survival with the addition of HIPEC (median overall survival of 41.6 months with HIPEC versus 32.7 months, I P i = 0.0209).
- Subjects
CYTOREDUCTIVE surgery; HYPERTHERMIC intraperitoneal chemotherapy; PERITONEAL cancer; PROGRESSION-free survival
- Publication
ANZ Journal of Surgery, 2019, Vol 89, Issue 9, p992
- ISSN
1445-1433
- Publication type
Article
- DOI
10.1111/ans.15424